ArticleJournal of hematology & oncology2020

CDK7 inhibitor THZ1 enhances antiPD-1 therapy efficacy via the p38α/MYC/PD-L1 signaling in non-small cell lung cancer.

Jian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.